Business
Grant of patent
Grant of patent.
About this update from Tristel Plc
[{"type":"text","content":"\n Tristel PLC\n03 January 2008\n\n\n\n TRISTEL plc\n\n\n\n Grant of Patent\n\n\n\nTristel plc ('Tristel'), the AIM listed provider of infection and contamination\ncontrol products, announces that it has been granted a patent by the European\nPatent Office for its chlorine dioxide generation system. The new patent, EPO\nno 1644051, relates to Tristel's Generator which is used to dispense Tristel's\nproprietary chlorine dioxide chemistry.\n\n\n\nTristel Generators are employed in the decontamination of endoscopes in a number\nof United Kingdom hospitals with Tristel products being used in over 375\nhospitals, representing some 60 per cent. of all UK NHS Acute & Private\nHospitals.\n\n\n\nTristel is in the process of adapting the Generator for use in buildings' water\nsupply systems, enhancing the capabilities of its Tristel Technologies\nsubsidiary which focuses upon legionella control.\n\n\n\nTristel operates through two subsidiaries: Tristel Solutions, which provides\ninfection control products based on chlorine dioxide chemistry to the healthcare\nmarketplace and Tristel Technologies, which uses chlorine dioxide chemistry for\nlegionella control in buildings' water systems (including those of hospitals)\nand contamination control in the food growing and processing industries.\n\n\n\nContacts:\n\n\nTristel plc\n\nPaul Swinney, Chief Executive Tel: 01638 721 500\n\nDaniel Stewart & Company Plc\nOliver Rigby Tel: 020 7776 6550\n\nParkgreen Communications Ltd Tel: 020 7851 7480\nPaul McManus Mob: 07980 541 893\n [email protected]\n\n\n\n\n\n\n\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange \n ","length":2066,"tagName":"div"}]